低分子肝素钙对生长受限胎儿脐动脉血流指标的影响

Abstract
Figure/Table
References (15)
Related Citation (12)

Download: PDF (0 KB) HTML (33 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effect of low molecular weight heparin calcium on umbilical artery blood flow indexes of fetal growth restriction.Methods A total of 80 pregnant women with fetal growth restriction who were admitted to our hospital from March 2018 to September 2019 were selected,and they were divided into two groups according to random number table method,40 cases in each group.The control group was given routine treatment,and observation group was given Low Molecular Weight Heparin Calcium based on the control group.The umbilical artery blood flow (umbilical artery flow resistance index [RI],umbilical artery peak systolic velocity/diastolic peak velocity [S/D]),maternal coagulation function indexes (activated partial thromboplastin time [APTT],prothrombin time [PT]) and neonatal Apgar score were compared between the two groups.Results There were no statistical differences in the umbilical artery flow indexes between two groups before treatment (P＞0.05).After treatment,the umbilical artery blood flow indexes in two groups were lower than those before treatment,and observation group was lower than control group,the neonatal Apgar score of observation group was higher than that of control group,and the differences were statistically significant (P＜0.05).There were no statistical differences in the maternal coagulation function indexes between two groups before and after treatment (P＞0.05).Conclusion Low Molecular Weight Heparin Calcium in treatment of fetal growth restriction can improve fetal umbilical artery blood flow indexes,increase neonatal Apgar score,and not affect coagulation function of pregnant women,which is worthy of clinical application.

Key words： Fetal growth restriction Low Molecular Weight Heparin Calcium Umbilical artery flow resistance index;Umbilical artery peak systolic velocity/diastolic peak velocity Activated partial thromboplastin time Prothrombin time;Neonatal Apgar score

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YANG Lin
	WANG Jia-yuan

Cite this article:

YANG Lin,WANG Jia-yuan. Effect of Low Molecular Weight Heparin Calcium on umbilical artery blood flow indexes of fetal growth restriction[J]. 中国当代医药, 2020, 27(31): 137-140.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2020/V27/I31/137

[1]	陈杉，朱锦明，栾晓梅，等.胎儿生长受限孕妇胎盘组织、血浆和胎儿脐血中内皮细胞蛋白C 受体的表达[J].中国临床研究，2019，32（8）：1015-1018.
[2]	乐杰，谢幸.妇产科学[M].第7版.北京：人民卫生出版社，2008：401.
[3]	李媛媛.低分子肝素治疗子痫前期合并胎儿生长受限的临床价值研究[J].中国伤残医学，2015，23（2）：135-136.
[4]	任国平，王保莲，毕春燕，等.丹参注射液联合肝素治疗胎儿生长受限的临床疗效及对孕妇血流变的影响[J].世界中医药，2017，12（5）：1032-1036.
[5]	汪萍，单腾飞.低分子肝素联合硫酸镁治疗胎儿生长受限的临床效果及可行性[J].中国妇幼保健，2017，32（17）：4171-4173.
[6]	严文彦，卢纹，欧燕珊.胎儿宫内生长受限采用低分子肝素治疗的临床效果分析[J].中国病案，2019，20（2）：102-104.
[7]	江志发，许燕滨，胡慧珍，等.低分子肝素早期干预治疗胎儿生长受限的临床效果监测[J].热带医学杂志，2019，19（6）：781-784.
[8]	蒋蕾，陈铎，李聪，等.低分子肝素在妊娠期的应用[J].中国临床医生杂志，2019，47（2）：152-154.
[9]	施素然，翁妍艳，黄江萍.低分子肝素联合复方氨基酸治疗胎儿生长受限的效果分析及对胎盘表皮生长因子胎盘生长因子表达的影响[J].中国药物与临床，2019，19（16）：2782-2783.
[10]	王俊虎，刘慧杰，郭云霞，等.低分子肝素联合低分子右旋糖酐治疗对胎儿宫内生长受限孕妇血液流变学及胎儿生长发育的影响[J].实用医院临床杂志，2019，16（6）：214-216.
[11]	金彦，朱敏，牛艳昕，等.低分子肝素联合硫酸镁治疗胎儿生长受限的效果及对围生儿结局的影响[J].中华全科医学，2018，16（10）：1677-1679.
[12]	袁燕，郑九生.低分子肝素在产科应用中的研究进展[J].现代妇产科进展，2016，25（8）：631-632.
[13]	程国梅，张琳瑛，陶贝贝.低分子肝素治疗胎儿生长受限的Meta 分析[J].中国妇幼保健，2015，30（27）：4755-4758.
[14]	伍冠.低分子肝素钠早期干预治疗胎儿生长受限的效果及对围生儿结局的影响[J].中国当代医药，2017，24（6）：83-85.
[15]	徐静，崔利娜，方丽丽，等.低分子肝素钠联合叶酸对胎儿生长受限的结局影响[J].中国合理用药探索，2019，16（8）：156-158.